Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Virus Infection, Response to Therapy of”

105 trials

Showing 20 of 105 results

Testing effectiveness (Phase 2)Study completedNCT01528735
What this trial is testing

This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 25
Not applicableUnknownNCT00272389
What this trial is testing

Prediction of Response to Treatment of Patients With Chronic HCV Infection by Genetic Profile

Who this might be right for
Hepatitis C Virus Chronic Infection
Hadassah Medical Organization 150
Post-approval studies (Phase 4)Study completedNCT00351403
What this trial is testing

Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
FGK Clinical Research GmbH 390
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Post-approval studies (Phase 4)UnknownNCT03402165
What this trial is testing

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Sherief Abd-Elsalam 1,200
Not applicableStudy completedNCT00700401
What this trial is testing

POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 262
Not applicableStudy completedNCT02402218
What this trial is testing

CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeS

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofHuman Immunodeficiency Virus
Johns Hopkins University 144
Large-scale testing (Phase 3)Study completedNCT01604850
What this trial is testing

Sofosbuvir + Ribavirin for 12 or 16 Weeks in Treatment Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection (FUSION)

Who this might be right for
Chronic Hepatitis C
Gilead Sciences 202
Testing effectiveness (Phase 2)Study completedNCT00217139
What this trial is testing

Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 60
Not applicableStudy completedNCT00606528
What this trial is testing

FGL2/Fibroleukin and Hepatitis C Virus Infection: A Predictor of Response to Antiviral Therapy

Who this might be right for
Chronic Hepatitis C Virus Infection
University Health Network, Toronto 54
Testing effectiveness (Phase 2)UnknownNCT05542615
What this trial is testing

Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).

Who this might be right for
Liver CirrhosisHepatitis C, ChronicEpigenetic Disorder
University of Guadalajara 60
Post-approval studies (Phase 4)Study completedNCT02339337
What this trial is testing

A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection

Who this might be right for
HBV/HCV Co-infection
Kaohsiung Medical University Chung-Ho Memorial Hospital 203
Large-scale testing (Phase 3)Ended earlyNCT02504099
What this trial is testing

Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular Carcinoma

Who this might be right for
Chronic Hepatitis C Infection
AbbVie 3
Not applicableUnknownNCT04251572
What this trial is testing

HCV Reinfection After DAA Therapy in PWID in Belgium

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy ofDrug Use
Hasselt University 100
Testing effectiveness (Phase 2)Study completedNCT00535847
What this trial is testing

A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond to Therapy

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 117
Not applicableStudy completedNCT02581020
What this trial is testing

The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects

Who this might be right for
Hepatitis C Virus
AbbVie 344
Testing effectiveness (Phase 2)Study completedNCT02413593
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 111
Not applicableStudy completedNCT00705224
What this trial is testing

Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)

Who this might be right for
Hepatitis C, ChronicHepatitis C Virus
Merck Sharp & Dohme LLC 250
Post-approval studies (Phase 4)UnknownNCT02008214
What this trial is testing

Efficacy of PTX+IFN Alpha+ RBV on Hepatitis C Virus Coinfected HIV Patients

Who this might be right for
HepacivirusHIV Infections
Centro Universitario de Ciencias de la Salud, Mexico 60
Testing effectiveness (Phase 2)Study completedNCT00968357
What this trial is testing

Proof-of-concept Study to Evaluate the Safety and Immunomodulatory Effects of SCV 07 as Monotherapy or in Combination With Ribavirin in Noncirrhotic Subjects With Chronic Hepatitis C Who Have Relapsed

Who this might be right for
Chronic Hepatitis C
SciClone Pharmaceuticals 40
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation